South Africa's Aspen Pharmacare has started registering GLP-1 drugs used to treat diabetes and obesity in markets where patents are expiring soon, for approval to start manufacturing and selling ...
By Nqobile Dludla JOHANNESBURG (Reuters) -Aspen Pharmacare posted a 5% rise in half-year earnings on Monday and said it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback